Showing results (521-530 of 542) with videos related to
Sort By:
Pageof 55
Gerontology|January 30, 2010
Predicting happiness among centenariansAlex J Bishop, Peter Martin, Maurice MacDonald, et al.Gerontology|January 30, 2010
Social resources and longevity: findings from the Georgia centenarian studyG Kevin Randall, Peter Martin, Maurice McDonald, et al.HIV Medicine|May 17, 2011
Long-term trends in CD4 cell counts and impact of viral failure in individuals starting antiretroviral therapy: UK Collaborative HIV Cohort (CHIC) studyR A Hughes, J A C Sterne, J Walsh, et al.Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition|June 4, 2010
Cognitive performance in centenarians and the oldest old: norms from the Georgia Centenarian StudyL Stephen Miller, Meghan B Mitchell, John L Woodard, et al.The Journal of Psychology|February 7, 2012
Life events and personality predicting loneliness among centenarians: findings from the Georgia Centenarian StudyBob Hensley, Peter Martin, Jennifer A Margrett, et al.Gerontology|January 30, 2010
Distal and proximal resource influences on economic dependency among the oldest oldMaurice MacDonald, Aradhana Aneja, Peter Martin, et al.Clinical Lymphoma, Myeloma & Leukemia|April 12, 2026
Comparison of Patient-Reported Outcomes for Elranatamab in MagnetisMM-3 Versus Real-World Physician Choice of Therapy for Triple-Class Refractory Multiple MyelomaBenjamin Hebraud, Charis Charalampous, Ricardo Parrondo, et al.Gerontology|January 30, 2010
Depression among centenarians and the oldest old: contributions of cognition and personalityJennifer Margrett, Peter Martin, John L Woodard, et al.International Journal of Antimicrobial Agents|March 13, 1999
Efficacy and safety of combination therapy with delavirdine and zidovudine: a European/Australian phase II trialA M Been-Tiktak, C A Boucher, F Brun-Vezinet, et al.Lancet (London, England)|April 20, 2004
Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN StudyF van Leth, P Phanuphak, K Ruxrungtham, et al.Pageof 55